Over the last decade, Grindeks has been focusing on its own brand portfolio, but under the new CEO we are shifting our business development strategy....
Financial results for “Grindeks” show that in the first half of 2025 – the company’s final year of transformation – the Group has achieved significant...
The leading pharmaceutical company in the Baltics, Grindeks, continues to strengthen its global presence by entering new export markets. This year, for the first time,...
20/02/2025
Choose your country/region website
NOTE: A new country/region website selection will open in a new tab
